Skip to main content
. 2020 Aug 17;20:292. doi: 10.1186/s12877-020-01682-w

Fig. 2.

Fig. 2

Effect of statins on the progression of cerebral small vessel disease in the cohort study. a The trends of changes in WMH volume; b the trends of changes in WMH-to-ICV ratio; c the cumulative hazard of the risk of WMH progression identified by the Fazekas scale; d the cumulative hazard of the risk of lacune progression; e the cumulative hazard of the risk of EPVS progression; f the cumulative hazard of the risk of microbleed progression. Abbreviations list: WMH, white matter hyperintensities; ICV, intracranial volume; EPVS, enlarged perivascular space